Amico Pharma Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Amico Pharma Pharmaceutical Export Portfolio Dataset — 3 Products, $831.8K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Amico Pharma — Pharmaceutical Exporter Profile (2026) | 3 Products, $831.8K Trade | TransData Nexus

Amico Pharma

Indian Pharmaceutical Exporter · Antihistamines & Allergy Specialist · $831.8K Total Trade · DGFT Verified

Amico Pharma is an Indian pharmaceutical exporter with a total trade value of $831.8K across 3 products in 3 therapeutic categories. Based on 69 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Chlorpheniramine ($583.3K), Norfloxacin ($187.7K), Paracetamol Caffeine ($60.8K).

Amico Pharma — Export Portfolio & Destination Treemap

Amico Pharma pharmaceutical export portfolio — 3 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Amico Pharma? — Company Overview & Market Position

Amico Pharma is an Indian pharmaceutical exporter specializing in the manufacture and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established by an award-winning entrepreneur, the company has been operational since 2001, focusing on providing high-quality medicines to various international markets. Its product portfolio encompasses a wide range of therapeutic categories, such as antibiotics, antimalarials, anti-cancer agents, NSAIDs, CNS drugs, cardiovascular medications, antifungals, and liquid injectables. These products are available in various dosage forms, including capsules, tablets, liquid orals, injectables, and ointments.

The company's manufacturing facilities adhere to international standards, with a WHO GMP certification ensuring the quality and reliability of its products. Amico Pharma's mission is to offer quality medicines at affordable prices, thereby improving human lives globally. The company has a significant presence in markets across Africa, Latin America, and parts of Asia, supplying products to hospitals, pharmacies, chemists, pharmaceutical wholesalers, health organizations, and medical centers.

What Does Amico Pharma Export? — Product Portfolio Analysis

Top Products by Export Value

1Chlorpheniramine$583.3K

Product Portfolio — Top 3 by Export Value

Amico Pharma exports 3 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Chlorpheniramine	Antihistamines & Allergy	$583.3K	49	1.3%	10
2	Norfloxacin	Advanced Antibiotics	$187.7K	10	2.3%	10
3	Paracetamol Caffeine	Combination Drugs	$60.8K	10	4.4%	5

Amico Pharma exports 3 pharmaceutical products across 3 therapeutic categories with a total export value of $831.8K. The top category is Antihistamines & Allergy (70.1% of portfolio), followed by Advanced Antibiotics (22.6%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Amico Pharma — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Amico Pharma operates state-of-the-art manufacturing facilities that comply with international standards, including WHO GMP certification. These facilities are equipped to produce a diverse range of pharmaceutical formulations, ensuring high-quality products for global markets. The company's manufacturing capabilities include the production of tablets, capsules, liquid orals, injectables, and ointments, catering to various therapeutic categories.

3Key Leadership

Specific details regarding the current CEO, CFO, and other key executives of Amico Pharma are not publicly disclosed. The company's leadership comprises highly qualified and experienced professionals from the pharmaceutical industry, who adhere to stringent production standards to ensure product quality. The team includes skilled technical professionals from the production floor to marketing executives, forming the backbone of Amico Pharma.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Amico Pharma Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Amico Pharma's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's focus has been on expanding into South and Central America, increasing its presence in brand marketing in West Africa, and exploring operations in CIS and Eastern European markets. However, specific regulatory filings, approvals, and market access statuses in these regions are not provided in the available information.

2Emerging Markets

Amico Pharma has made significant inroads into emerging markets, particularly in Africa, Latin America, and parts of Asia. The company's expansion strategy includes increasing its presence in brand marketing in West Africa and exploring operations in CIS and Eastern European markets. While the available information does not specify WHO prequalification status, the company's adherence to WHO GMP standards suggests a commitment to meeting international quality benchmarks, which is crucial for accessing and expanding in these emerging markets.

3Geographic Strategy

Amico Pharma — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Amico Pharma's FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available. The company's focus has been on expanding into markets such as South and Central America, West Africa, and parts of Asia. While the available information does not provide insights into FDA approvals or inspections, the company's adherence to WHO GMP standards indicates a commitment to maintaining high-quality manufacturing practices.

2WHO & EU GMP

Amico Pharma's manufacturing facilities are WHO GMP certified, ensuring that its products meet international quality standards. However, specific details regarding EU GMP certificates and EDQM status are not provided in the available sources. The company's adherence to WHO GMP standards underscores its commitment to producing high-quality pharmaceutical formulations for global markets.

3CDSCO & Indian Regulatory

Specific details regarding Amico Pharma's CDSCO manufacturing licenses, state drug controller approvals, and export NOCs are not publicly disclosed. The company's focus has been on expanding into international markets, including South and Central America, West Africa, and parts of Asia. While the available information does not provide insights into Indian regulatory approvals, the company's adherence to WHO GMP standards suggests compliance with international manufacturing practices.

Amico Pharma — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Amico Pharma operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific competitors are not identified in the available information, the company's focus on quality, affordability, and adherence to international standards positions it favorably in the market. The company's expansion into emerging markets and its diverse product portfolio further enhance its competitive standing.

2Key Differentiators

Amico Pharma's key differentiators include its commitment to quality, as evidenced by its WHO GMP certification, and its focus on providing affordable medicines to a wide range of therapeutic categories. The company's strategic expansion into emerging markets and its diverse product portfolio further distinguish it in the pharmaceutical export sector.

3Strategic Position

Amico Pharma's current strategic direction focuses on expanding its presence in emerging markets, including South and Central America, West Africa, and parts of Asia. The company's adherence to WHO GMP standards and its commitment to quality manufacturing practices support its strategic objectives. Future outlooks suggest continued growth and diversification, leveraging the company's strengths in quality production and market expansion.

Buyer Due Diligence Brief — Evaluating Amico Pharma as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Amico Pharma has a track record of supplying a diverse range of pharmaceutical formulations to international markets. The company's export volume and consistency are supported by its adherence to WHO GMP standards and its focus on quality manufacturing practices. Reliability indicators include the company's strategic expansion into emerging markets and its commitment to providing affordable medicines across various therapeutic categories.

2Certifications to Verify

Importers should verify the following certifications when considering Amico Pharma as a supplier:

WHO GMP Certification: Ensures compliance with international manufacturing standards. Verification can be done through the World Health Organization's official website or by contacting Amico Pharma directly.

EU GMP Certification: Indicates adherence to European manufacturing standards. Verification can be conducted through the European Medicines Agency (EMA) or by reaching out to Amico Pharma.

Frequently Asked Questions — Amico Pharma

How many pharmaceutical products does Amico Pharma export from India?

Amico Pharma exports 3 pharmaceutical products across 3 therapeutic categories. The top exports are Chlorpheniramine ($583.3K), Norfloxacin ($187.7K), Paracetamol Caffeine ($60.8K). Total export value is $831.8K.

What is Amico Pharma's total pharmaceutical export value?

Amico Pharma's total pharmaceutical export value is $831.8K, based on 69 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Amico Pharma cover?

Amico Pharma exports across 3 therapeutic categories. The largest are Antihistamines & Allergy (70.1%, 1 products), Advanced Antibiotics (22.6%, 1 products), Combination Drugs (7.3%, 1 products).

Get Full Amico Pharma Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.